Deadline now extended for PSA’s discussion paper

The Pharmaceutical Society of Australia (PSA) is extending its deadline for the ‘Pharmacists in 2023’ discussion paper to next Friday (September 14).

In response to stakeholder requests, PSA is extending the consultation period on the paper (http://www.psa.org.au/wp-content/uploads/Pharmacists-in-2023-Discussion-Paper.pdf) from the original deadline of today (September 7).

“We have already received a number of incredibly detailed submissions and want to ensure all stakeholders have enough time to address the important issues of embedding, equipping and enabling pharmacists,” PSA General Manager, Policy & Advocacy Belinda Wood said.

“If you are interested in shaping the future of the pharmacist profession, PSA encourages you to make a submission.”

Must Read

MM2024: Australia’s largest (and greenest) scientific pharmacy conference ignites in Adelaide

0
Medicines Management 2024 opens with strong sustainability focus, a new international partnership and release of the long-awaited AdPha Clinical Pharmacy Standards. Advanced Pharmacy Australia (AdPha)’s...